Case Report
Treatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves’ Disease: A Report on Two Cases
Table 1
Laboratory results of Patients 1 and 2 at time of TTP diagnosis and over the course after TTP therapy.
| Patient 1 | Patient 2 |
| TSH (0.34.4.94 mIU/L) |
| basal | <0.1 | basal | <0.1 | 3 weeks | 0.53 | 5 weeks | 4.36 | 24 months | 2.78 | 6 months | 1.66 | 31 months | 2.48 | 15 months | 0.99 |
| FT3 (1.71-3.71 pg/ml) | | | |
| basal | 7.00 | basal | 12.7 | 3 weeks | 1.01 | 5 weeks | 3.40 | 24 months | 3.16 | 6 months | 3,17 | 31 months | 3.24 | 15 months | 3.64 |
| FT4 (9.3-17.0 pg/ml) | | | |
| basal | 19.7 | basal | 30.7 | 3 weeks | 5.4 | 5 weeks | 6.9 | 24 months | 11.5 | 6 months | 12.4 | 31 months | 11.8 | 15 months | 15.7 |
| TRAb (<1.75 U/L) | | | |
| basal | 28.3 | basal | 10.1 | after 1. PE | 5.4 | | | 10 days | 1.8 | 2 weeks | 2.7 | 24 months | 0.3 | 8 months | 1.5 | 31 months | 1.8 | 15 months | <0.8 |
|
|